Key Insights

Highlights

Treatment Research

1 treatments under study, led by Thioctic Acid

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 4 (1)

Trial Status

Unknown1

Clinical Trials (1)

Research Network

Common Treatments

  • Thioctic Acid1

Active Sponsors

  • Dar EL Salam Cancer Hospital1
  • Ain Shams University1

Top Investigators

Related Conditions

  • Breast Cancer1
  • Chemotherapy1
  • Neurologic Disorder1
  • Paclitaxel1

Activity Timeline